India could resume deliveries of COVID-19 shots to global vaccine-sharing platform COVAX in a few weeks for the first time since April, two health industry sources said, ending a suspension of supplies that has hurt poor countries.The World Health Organization (WHO), which co-leads COVAX, has been urging India to restart supplies for the programme, especially after it sent about 4 million doses to its neighbours and partners in October.Based on an informal approval from India, COVAX officials have started planning allocations of the Covishield shot for various countries, said one of the sources, both of whom declining to be identified pending a final agreement. Covishield is a licensed version of the AstraZeneca (AZN.L) shot made by the Serum Institute of India (SII), the world’s biggest vaccine maker. SII has nearly quadrupled its output of Covishield to up to 240 million doses a month since April, when India stopped all exports in order to inoculate its own people during a surge of cases. View More…..